Association of antipsychotic use with breast cancer: a systematic review and meta-analysis of observational studies with over 2 million individuals.
Janice Ching Nam LeungDora Wai Yee NgRachel Yui Ki ChuEdward Wai Wa ChanLei HuangDawn Hei LumEsther Wai Yin ChanDaniel J SmithIan Chi Kei WongFrancisco Tsz Tsun LaiPublished in: Epidemiology and psychiatric sciences (2022)
Antipsychotic use is moderately associated with breast cancer, possibly mediated by prolactin-elevating properties of certain medications. This risk should be weighed against the potential treatment effects for a balanced prescription decision.